SLC31A1 and ovarian cancer: By analyzing a publicly available database containing 91 ovarian cancers, Ishida et al. [70] reported that patients with high hCtr1 levels were associated with longer disease-free survival time after adjuvant chemotherapy with a Pt drug and taxane.